A randomized phase 2 study of durvalumab monotherapy and in combination with tremelimumab in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): ALPS study Meeting Abstract
| Authors: | O'Reilly, E. M.; Oh, D. Y.; Dhani, N.; Renouf, D. J.; Lee, M. A.; Sun, W.; Fisher, G. A.; Hezel, A. F.; Chang, S. C.; Vlahovic, G.; Takahashi, O.; Yang, Y.; Philip, P. A. |
| Abstract Title: | A randomized phase 2 study of durvalumab monotherapy and in combination with tremelimumab in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): ALPS study |
| Meeting Title: | 2018 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2018 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000436174100208 |
| DOI: | 10.1200/JCO.2018.36.4_suppl.217 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 217 -- Source: Wos |
